BIOA earnings: real EPS beat/miss history, analyst consensus Buy, P/E -9.14. Updated 2026-07-23.
BioAge Labs (BIOA) Research Hub
BioAge Labs (BIOA) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 8.49 USD (-7.42%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -9.14, market cap 0.83B. This hub links to the full technical, earnings and options research available for BIOA.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 8.49 USD (-7.42%) |
| 52-week range | 8.31 USD – 25.96 USD |
| Trend regime | Range |
| 14-day RSI | 19.9 (Oversold) |
| Trailing P/E | -9.14 |
| Market cap | 0.83B |
| Dividend yield | 0.00% |
Available research for BIOA
Covered Call on BIOA: how it works, illustrative setup around the real 8.49 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on BIOA: how it works, illustrative setup around the real 8.49 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on BIOA: how it works, illustrative setup around the real 8.49 USD price, max profit/loss, breakeven and when to use it. Educational.
BIOA technical analysis: range, last 8.49 USD, RSI 19.9, 52w range 8.31 USD–25.96 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is BIOA in?
BioAge Labs (BIOA) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is BIOA in an uptrend or downtrend?
As of 2026-09-11, BIOA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is BIOA's trailing P/E ratio?
BIOA's trailing P/E is -9.14, with a market cap of 0.83B. See the earnings research page for full valuation detail.